Sarah M. Cheal

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Jeremy C. Durack et al. · Clinical Cancer Research · 2015 · 203 citations · Full text

Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions

Michelle S. Bradbury, Evan H. Phillips, Pablo H. Montero et al. · Integrative Biology · 2012 · 176 citations · Full text

Nanoparticles, Surgical Oncology, Engineering +24

89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Volkan Beylergil et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 150 citations · Full text

Positron Emission Tomography, 89Zr-huj591 Immuno-pet Imaging, Urology +11

First-in-Human Imaging with ⁸⁹Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake

Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Shutian Ruan et al. · Journal of Nuclear Medicine · 2016 · 137 citations · Full text

Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3

Mahiuddin Ahmed, Ming Cheng, Qi Zhao et al. · Journal of Biological Chemistry · 2015 · 110 citations · Full text

Crystal Structure, Radiation Oncology, Tumor Immunology +15